Fusion Pharmaceuticals · 1 month ago
Imaging Scientist, Theranostics
Boston, Boston, MA, US
Full-time
Hybrid
Senior Level
$87K/yr - $130K/yr
5+ years expFusion Pharmaceuticals, a member of the AstraZeneca Group, is a clinical-stage oncology company focused on developing next-generation radioconjugates as precision medicines. The Imaging Scientist, Theranostics will assist in the development and management of imaging trial documents, provide expertise in image acquisition and processing, and collaborate with clinical operations to ensure quality in imaging-related aspects of clinical studies.
BiopharmaBiotechnologyMedicalOncologyPharmaceutical
Responsibilities
Assist in the development of, and adherence to, imaging trial documents (e.g., Image Review Charter, Imaging Manual, Data Transmittal Forms, and Dosimetry Manuals)
Provide subject matter expertise to internal and external stakeholders in matters of image acquisition, storage, review, and processing
Maintain an archive of imaging related data for ongoing and completed trials
Collaborate with clinical operations in the oversight, conduct and management of imaging-related aspects of clinical studies in accordance with the clinical protocol, study manuals and plans, and timelines while ensuring quality in accordance with GCP and ICH guidelines
Assist with the management of in-house processing of image data and internal dosimetry efforts to support ongoing research and multi-disciplinary department and company initiatives
Provide support for clinical data review; assist in generation of clinical research reports and presentations including abstracts, posters, and publications
Provide support to clinical site staff and investigators pertaining to preparation, administration, and waste management of imaging and therapeutic radiopharmaceuticals
Respond to radiation safety questions and concerns regarding the use of diagnostic and therapeutic radiopharmaceuticals and precautions
Have a working knowledge and understanding of modern electronic infrastructures relevant to radiological imaging such as DICOM, PACS, IHE models, image processing and advanced visualization
Willingness to travel when needed (5-10%)
Qualification
Required
The candidate should have a Bachelor of Science degree with a life science focus from an accredited educational institution and NMTCB/ARRT(N) certification in nuclear medicine or equivalent
Minimum of at least 5 years of clinical experience
Demonstrated technical and analytical problem-solving skills
Ability to clearly articulate and present the role and impact of molecular imaging on decision making within drug discovery and development
Self-motivation and exceptional verbal and written communication skills
Ability to multi-task and work effectively in a team or independently on assigned tasks
Preferred
Additional training in radiation safety (NMTCB(RS)) and/or medical physics with an advanced master's qualifications
Experience working in clinical trials for 2-5 years
Scientific expertise in SPECT and PET imaging is strongly preferred, including acquisition, reconstruction and uploading of images
Training in Good Clinical Practices (GCP), Quality Assurance/Compliance (QA/QC) in a clinical trial setting is preferred
Experience with radioactive materials license amendment process with the NRC and Agreement States
Familiar with Radiation Safety Officer (RSO) responsibilities
Proficiency in business computer skills and experience with medical imaging workstations (i.e., MIM), dosimetry software, and/or PACS preferred
Benefits
Qualified retirement programs
Paid time off (i.e., vacation, holiday, and leaves)
Health, dental, and vision coverage in accordance with the terms of the applicable plans
Company
Fusion Pharmaceuticals
Fusion Pharmaceuticals is a clinical-stage oncology company focused on developing radiopharmaceuticals.
11-50 employees
Funding
Current Stage
Public CompanyTotal Funding
$230.91MKey Investors
CPP InvestmentsJohnson & Johnson Development Corporation
2024-03-19Acquired
2023-02-13Post Ipo Equity· $60M
2020-06-25IPO
Leadership Team
Dmitri Bobilev
Chief Medical Officer
Eric Burak
Chief Technical Officer
Recent News
caixinglobal.com
2025-11-25
Company data provided by crunchbase